Sakthivel K, Balasubramanian R, Sampathrajan V, Veerasamy R, Appachi S, K K K
Funct Integr Genomics. 2025; 25(1):27.
PMID: 39871009
DOI: 10.1007/s10142-025-01538-9.
Kumru H, Kofler M, Albu S, Vidal J, Benito J
Acta Neurol Belg. 2024; 124(5):1631-1640.
PMID: 38763965
DOI: 10.1007/s13760-024-02524-x.
Rouyar A, Patil A, Leon-Norena M, Li M, Coutinho-Abreu I, Akbari O
Front Physiol. 2024; 15:1381164.
PMID: 38606012
PMC: 11008680.
DOI: 10.3389/fphys.2024.1381164.
Hone A, McIntosh J
Pharmacol Res. 2023; 190:106715.
PMID: 36868367
PMC: 10691827.
DOI: 10.1016/j.phrs.2023.106715.
Jobin M, Siddig S, Koszegi Z, Lanoiselee Y, Khayenko V, Sungkaworn T
Nat Commun. 2023; 14(1):34.
PMID: 36596803
PMC: 9810740.
DOI: 10.1038/s41467-022-35708-1.
Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review.
Fischler P, Soyka M, Seifritz E, Mutschler J
Front Pharmacol. 2022; 13:927703.
PMID: 36263121
PMC: 9574013.
DOI: 10.3389/fphar.2022.927703.
Class A and C GPCR Dimers in Neurodegenerative Diseases.
Caniceiro A, Bueschbell B, Schiedel A, Moreira I
Curr Neuropharmacol. 2022; 20(11):2081-2141.
PMID: 35339177
PMC: 9886835.
DOI: 10.2174/1570159X20666220327221830.
Presynaptic mechanisms underlying GABA-receptor-mediated inhibition of spontaneous neurotransmitter release.
Alten B, Guzikowski N, Zurawski Z, Hamm H, Kavalali E
Cell Rep. 2022; 38(3):110255.
PMID: 35045279
PMC: 8793855.
DOI: 10.1016/j.celrep.2021.110255.
Allosteric ligands control the activation of a class C GPCR heterodimer by acting at the transmembrane interface.
Liu L, Fan Z, Rovira X, Xue L, Roux S, Brabet I
Elife. 2021; 10.
PMID: 34866572
PMC: 8700296.
DOI: 10.7554/eLife.70188.
A Brief History and the Significance of the GABA Receptor.
Vlachou S
Curr Top Behav Neurosci. 2021; 52:1-17.
PMID: 34595739
DOI: 10.1007/7854_2021_264.
GABA Receptors and Cognitive Processing in Health and Disease.
Vlachou S
Curr Top Behav Neurosci. 2021; 52:291-329.
PMID: 34382179
DOI: 10.1007/7854_2021_231.
GABA Receptors and Drug Addiction: Psychostimulants and Other Drugs of Abuse.
Li X, Slesinger P
Curr Top Behav Neurosci. 2021; 52:119-155.
PMID: 33442842
DOI: 10.1007/7854_2020_187.
A randomized phase 1 single-dose polysomnography study of ASP8062, a GABA receptor positive allosteric modulator.
Walzer M, Wu R, Ahmad M, Freeman J, Zammit G, Marek G
Psychopharmacology (Berl). 2021; 238(3):867-876.
PMID: 33433644
PMC: 7914186.
DOI: 10.1007/s00213-020-05738-y.
Targeting receptor complexes: a new dimension in drug discovery.
Rosenbaum M, Clemmensen L, Bredt D, Bettler B, Stromgaard K
Nat Rev Drug Discov. 2020; 19(12):884-901.
PMID: 33177699
DOI: 10.1038/s41573-020-0086-4.
Spinal Inhibition of GABAB Receptors by the Extracellular Matrix Protein Fibulin-2 in Neuropathic Rats.
Papon M, Le Feuvre Y, Barreda-Gomez G, Favereaux A, Farrugia F, Bouali-Benazzouz R
Front Cell Neurosci. 2020; 14:214.
PMID: 32765223
PMC: 7378325.
DOI: 10.3389/fncel.2020.00214.
Advances in novel molecular targets for antidepressants.
Wang Q, Dwivedi Y
Prog Neuropsychopharmacol Biol Psychiatry. 2020; 104:110041.
PMID: 32682872
PMC: 7484229.
DOI: 10.1016/j.pnpbp.2020.110041.
Binding of clozapine to the GABA receptor: clinical and structural insights.
Nair P, McKinnon R, Miners J, Bastiampillai T
Mol Psychiatry. 2020; 25(9):1910-1919.
PMID: 32203158
DOI: 10.1038/s41380-020-0709-5.
Rational approaches for the design of various GABA modulators and their clinical progression.
Bhagat K, Singh J, Pagare P, Kumar N, Sharma A, Kaur G
Mol Divers. 2020; 25(1):551-601.
PMID: 32170466
PMC: 8422677.
DOI: 10.1007/s11030-020-10068-4.
Direct Interaction of PP2A Phosphatase with GABA Receptors Alters Functional Signaling.
Li X, Terunuma M, Deeb T, Wiseman S, Pangalos M, Nairn A
J Neurosci. 2020; 40(14):2808-2816.
PMID: 32111696
PMC: 7117905.
DOI: 10.1523/JNEUROSCI.2654-19.2020.
Physiology and Pathophysiology of Itch.
Cevikbas F, Lerner E
Physiol Rev. 2019; 100(3):945-982.
PMID: 31869278
PMC: 7474262.
DOI: 10.1152/physrev.00017.2019.